Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy

  • Hironobu Yanagie
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Novriana Dewi
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Syushi Higashi
    Department of Surgery, Kojinkai Medical City East Hospital, Miyazaki, Japan
  • Ichiro Ikushima
    Department of Radiology, Miyakonojyo Metropolitan Hospital, Miyazaki, Japan
  • Koji Seguchi
    Department of Surgery, Kojinkai Medical City East Hospital, Miyazaki, Japan
  • Ryoji Mizumachi
    Department of Pharmacology, Kumamoto Institute Branch, LSI Medience Co. Ltd, Kumamoto, Japan
  • Yuji Murata
    Department of Pharmacology, Kumamoto Institute Branch, LSI Medience Co. Ltd, Kumamoto, Japan
  • Yasuyuki Morishita
    Department of Human and Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Atsuko Shinohara
    Department of Humanities, The Graduate School of Seisen University, Tokyo, Japan
  • Shoji Mikado
    Department of Physics, College of Industrial Technology, Nihon University, Chiba, Japan
  • Nakahiro Yasuda
    Research Institute of Nuclear Engineering, University of Fukui, Fukui, Japan
  • Mitsuteru Fujihara
    SPG Technology Co. Ltd, Miyazaki, Japan
  • Yuriko Sakurai
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Kikue Mouri
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Masashi Yanagawa
    Veterinary Medical Center, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan
  • Tomoya Iizuka
    Department of Veterinary Surgery, The University of Tokyo Veterinary Hospital, Tokyo, Japan
  • Minoru Suzuki
    Research Reactor Institute, Kyoto University, Osaka, Japan
  • Yoshinori Sakurai
    Research Reactor Institute, Kyoto University, Osaka, Japan
  • Shin-ichiro Masunaga
    Research Reactor Institute, Kyoto University, Osaka, Japan
  • Hiroki Tanaka
    Research Reactor Institute, Kyoto University, Osaka, Japan
  • Takehisa Matsukawa
    Department of Epidemiology and Environmental Health, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Kazuhito Yokoyama
    Department of Epidemiology and Environmental Health, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Takashi Fujino
    Department of Pathological Diagnosis, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan
  • Koichi Ogura
    Department of Physics, College of Industrial Technology, Nihon University, Chiba, Japan
  • Yasumasa Nonaka
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Hirotaka Sugiyama
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Tetsuya Kajiyama
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Sho Yui
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Ryohei Nishimura
    Department of Veterinary Surgery, The University of Tokyo Veterinary Hospital, Tokyo, Japan
  • Koji Ono
    Research Reactor Institute, Kyoto University, Osaka, Japan
  • Sinichi Takamoto
    Department of Cardiac Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Jun Nakajima
    Cooperative Unit of Medicine and Engineering, The University of Tokyo Hospital, Tokyo, Japan
  • Minoru Ono
    Cooperative Unit of Medicine and Engineering, The University of Tokyo Hospital, Tokyo, Japan
  • Masazumi Eriguchi
    Department of Innovative Cancer Therapeutics: Alpha Particle and Immunotherapeutics, Meiji Pharmaceutical University, Tokyo, Japan
  • Kenichiro Hasumi
    Hasumi International Research Foundation, Tokyo, Japan
  • Hiroyuki Takahashi
    Department of Nuclear Engineering and Management, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (29)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ